{"schema_version":"secwatch.filing_event.v1","accession":"0001564590-21-036895","form_type":"8-K","ticker":"ENTA","cik":"0001177648","company_name":"ENANTA PHARMACEUTICALS INC","filed_at":"2021-07-16T23:59:59+00:00","discovered_at":"2026-05-14T18:04:17.384357+00:00","generated_at":"2026-06-30T04:44:46.007475+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Enanta CMO Nathalie Adda to retire Feb 28, 2022; consulting deal signed","bullets":["Nathalie Adda, MD, SVP and CMO, announced retirement effective February 28, 2022.","Enanta entered a consulting agreement for up to 3 months post-retirement at $450/hour for up to 70 hours/month.","Existing stock options and restricted stock units will continue to vest during the consulting term."],"urls":{"canonical":"https://secwatch.observer/filing/0001564590-21-036895","json":"https://secwatch.observer/filing/0001564590-21-036895.json","markdown":"https://secwatch.observer/filing/0001564590-21-036895.md","text":"https://secwatch.observer/filing/0001564590-21-036895.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1177648/000156459021036895/0001564590-21-036895-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1177648/000156459021036895/enta-8k_20210714.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-30T04:44:46.007475+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3bcdf4b115","claim":"Nathalie Adda departed as Senior Vice President, Chief Medical Officer at ENANTA PHARMACEUTICALS INC.","evidence_excerpt":"On July 14, 2021, Nathalie Adda, M.D., Senior Vice President, Chief Medical Officer of Enanta Pharmaceuticals, Inc. (“Enanta”) announced her retirement effective February 28, 2022 (the “Effective Date”).","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1177648/000156459021036895/0001564590-21-036895-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"announced her retirement"},{"label":"Role","value":"Senior Vice President, Chief Medical Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}